Concepedia

Wilhelm Ridderstråle

WR

Statistics

Publications

11

Citations

1K

H-Index

11

Active since

2005

Affiliations

Uppsala University(Current)

AstraZeneca (Sweden)

University of Toronto

St. Michael's Hospital

Sorbonne Université

Wilhelm Ridderstråle is an author at Uppsala University specializing in medicine, cardiology, and cardiovascular pharmacotherapy.

Publications per year

2005–2024

11

Publications

11

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Philippe Gabríel Steg, Deepak L. Bhatt, Tabassome Simon et al. · New England Journal of Medicine · 2019 · 362 citations · Full text

, , +17

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Stefan James, David Erlinge, Robert F. Storey et al. · NEJM Evidence · 2023 · 271 citations

, , +17

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

, , +15

Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy

Wilhelm Ridderstråle, Erik Ulfhammer, Sverker Jern · Hypertension · 2006 · 40 citations · Full text

, , +17

Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction

Stefan James, David Erlinge, Robert F. Storey et al. · American Heart Journal · 2023 · 34 citations · Full text

, , +17

1–5 of 11